NGM Biopharmaceuticals, Inc.
ANGPTL8-binding agents and methods of use thereof

Last updated:

Abstract:

The present disclosure provides binding agents, such as antibodies, that specifically bind Angiopoietin-like protein 8 (ANGPTL8), including human ANGPTL8, and methods of their use.

Status:
Grant
Type:

Utility

Filling date:

8 Nov 2018

Issue date:

15 Sep 2020